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Abstract The forensic utility of N-acetyltaurine (NAcT) in
urine as a marker for ethanol intake was examined. A
HILIC-based liquid chromatography method for the mass
spectrometric determination of NAcT, taurine, and creatinine
in urine was developed and validated to investigate NAcT
formation and elimination in a drinking study. Thereby, eight
subjects ingested 0.66 to 0.84 g/kg alcohol to reach a blood
alcohol concentration (BAC) of 0.8 g/kg. Blood and urine
were taken every 1.5–2 h, during the first 8 h. NAcT and
taurine levels were measured and corrected for the urine’s
dilution by normalization to a creatinine concentration of
1 mg/mL. For the determination of NAcT and taurine, uncor-
rected lower limits of quantitation (LLOQs) were at 0.05 μg/
mL of urine. In the drinking study, NAcT proved to be an
endogenous compound, which is present at a range of 1.0 to
2.3 μg/mL in urine of alcohol-abstinent subjects. Maximum
NAcT concentrations were reached in samples taken 3 to 6 h
after the start of drinking, whereby an upregulation in N-
acetyltaurine could be found for all the subjects. The mean
peak concentrations (c̅max) of 14 ± 2.6 μg/mL (range 9–
17.5 μg/mL) were reached. Within 24 h, the NAcT levels
declined to endogenous concentrations. The detectability of
NAcT was found to be slightly shifted compared to BAC:
When BAC was not detectable anymore, NAcT levels were
still elevated. After 24 h, when ethyl glucuronide (EtG) and
ethyl sulfate (EtS) were still detectable, NAcT concentrations
showed endogenous levels again. Positive NAcT results can
be used as an indicator for recent alcohol consumption. A
direct relationship between NAcT and taurine concentrations
could not be found.
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Introduction
Alcohol abuse and its medical and social effects pose a
major challenge in today’s society. Of all the deaths, 5.9 %
are directly linked to excessive alcohol consumption [1]. In
order to prove alcohol abstinence, various direct alcohol
markers are currently analyzed in blood, urine, and hair,
such as ethyl glucuronide (EtG), ethyl sulfate (EtS), and
phosphatidylethanol (PEth) [2]. N-Acetyltaurine (NAcT)
was found to be an ethanol-related direct marker in mice and
is generally not included in routine analysis [3]. The suitability
and detectability of NAcT as a forensic marker in human be-
ing have not been investigated so far [4]. The formation of
NAcT requires taurine, acetyl-CoA, and/or acetate as a sub-
strate [3]. As acetate and acetyl-CoA are closely related to
ethanol metabolism, NAcT levels increase after alcohol con-
sumption [5]. An increase of NAcT has also been observed
after an endurance exercise, such as a marathon, mostly due to
the ketogenic state of the body. During this period, acetate is
produced, which serves as an acetyl donor for the formation of
NAcT from taurine. The concentration of NAcT after such an
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endurance exercise was reported to be around 2.8 μg/mL [6].
In this paper, we provide detailed profiles of NAcT concen-
trations in human urine during the course of a drinking study:
Our results provide an overview of the endogenous NAcT
concentrations of abstinent persons and its increase after the
consumption of a predefined amount of alcohol.
Materials and methods
Reagents
Taurine, acetic anhydride, creatinine, and creatinine-d3 were
obtained from Sigma-Aldrich (St. Louis, USA). Ethanol, pyr-
idine, acetic acid, and ammonium acetate were purchased
fromMerck (Darmstadt, Germany). Water was produced with
a Milli-Q water system from Millipore (Billerica, USA).
Taurine-d4 was ordered from Toronto Research Chemicals
(Toronto, Canada). Acetonitrile, p.a., was obtained from
Acros Organics (Geel, Belgium). Acetyltaurine was obtained
from Carbosynth (Berkshire, UK). Deuterated DMSO
(99.9 %) was obtained from Cambridge Isotope Laboratories
(Tewksbury, MA, USA).
Synthesis of internal standard
Deuterated NAcTwas synthesized by dissolving 2 mg of tau-
rine-d4 in 400 μL of water. Then, 143 μL pyridine and 115μL
acetic anhydride were added. The reaction mixture was stirred
for 20 h at room temperature. The solvents were evaporated to
dryness at 60 °C under vacuum (approximately 0.18 bar) with
a CentriVap concentrator from Labconco® (Biolabo Scientific
Instruments, Switzerland). The residue was reconstituted in
0.8 mL water and stored at −20 °C.
Drinking study design
Eight volunteers (six men and two women, aged 19 to
26 years), who had been abstinent for at least 2 weeks,
ingested a single dose of alcohol (66 proof/37.5 % vodka
mixed with a soft drink), which led to an approximate blood
alcohol concentration (BAC) of 0.8 g/kg. The alcohol doses
(125–210 mL) were calculated for each person by the
Widmark formula with individually adjusted reduction factors
based on the weight and size of the individual [7]. Blank blood
and urine samples were obtained from all subjects prior to the
experiment. One hundred minutes after the start of drinking,
the first blood and urine samples were taken. Three more
samples were taken during the next 5 h. Further, urine samples
were taken every 24 h after the experiment for 96 h. The
presented procedure is based on the drinking study procedure
for fatty acid ethyl ester determination [8].
Determination of BAC
BAC was determined in lithium-heparinized blood by a vali-
dated headspace gas chromatography method with flame ion-
ization detection (HS-GC-FID). According to Swiss forensic
guidelines, the samples were analyzed with two different GC-
FID systems with two measurements each, analogously to
BAC determination in serum [9].
Determination of EtG and EtS
EtG and EtS in urine were analyzed by a validated LC-MS/
MS method. The method is used for routine analysis at the
Institute of Forensic Medicine Bern for samples from with-
drawal therapy to monitor abstinence [7].
NMR spectroscopy
NMR data were collected on a Bruker Avance II (500 MHz;
1H) spectrometer from Bruker BioSpin (Fällanden,
Switzerland) equipped with a 1.7-mm triple-resonance (1H,
13C, 31P) micro-probe head. Approximately 0.5 mg of NAcT
(used as received) was dissolved in 45 μL of DMSO-d6 and
transferred into 1.7-mm NMR tubes. All spectra were record-
ed and processed using the TopSpin® software (version 3.2,
Bruker BioSpin). One-dimensional (1D) 1H-NMR experi-
ments were recorded using the standard zg30 pulse program
of the Bruker pulse sequence library. The spectral width was
12,000 Hz; a 2-μs pulse (30° tip angle) was applied; the ac-
quisition time was 2.62 s, corresponding to 65,536 complex
points; and the relaxation delay was 10 s to ensure quantitative
conditions. The spectrum was recorded using 128 scans, for a
total experimental time of approximately 25 min. All FID
values were multiplied by an exponential function with a
0.3-Hz broadening line prior to Fourier transformation and
zero-filled to 131,072 data points. Spectra were processed
using automatic phasing, baseline correction and calibrated
to the residual DMSO peak (δ 2.50 ppm). The purity of
NAcT was estimated by comparing the integral of the CH2-
SO3H protons of NAcT at δ 2.69 ppm with the integral of the
protons of a CH2 group from an impurity at δ 2.88 ppm.
Instrumentation for NAcT analysis
The liquid chromatography-mass spectrometry system
consisted of an UltiMate® 3000 UHPLC+ focused system
with an UltiMate® 3000 RS autosampler and a heated column
compartment from Dionex (Olten, Switzerland) connected to
a QTrap 5500 mass spectrometer from Sciex (Toronto,
Canada). The whole system was controlled by Analyst 1.6.2
software. Chromatographic separation was performed with a
SeQuant® ZIC®-HILIC 3.5-μm, 100 Å, 150 × 2.1 mm
PEEK-coated HPLC column from Merck (Darmstadt,
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Germany), heated at 30 °C, with a flow rate of 0.3 mL/min.
Mobile phase A consisted of a 5 mM ammonium acetate buff-
er at pH 5.72 with 0.1 % formic acid, and mobile phase B
consisted of acetonitrile with 0.1 % formic acid. The analytes,
depicted in Table 1, were separated with the following 14-min
gradient: 0 to 1 min, 95%B; 1 to 4.5 min, 95 to 20%B linear;
4.5 to 9 min, 20 % B; 9 to 10 min, 20 to 95 % B linear; and 10
to 14 min, 95 % B. The mass spectrometer was operated in
electrospray negative selected reaction monitoring (SRM)
mode with an ion spray voltage of −4250 V and a source
temperature of 550 °C, collision gas at 40, curtain gas at 35,
gas 1 at 40, and gas 2 at 40. The resulting cycle time was
0.275 s.
Determination of N-acetyltaurine, taurine, and creatinine
Urine samples were prepared by adding 50 μL of urine to-
gether with 150 μL acetonitrile (containing the internal stan-
dards) into a 2-mL Eppendorf tube and shaking at 1500 rpm
on a VXR basic Vibrax (IKA, Staufen, Germany). Afterwards,
the samples were centrifuged for 10 min at 16,000g and
100 μL of the supernatant was transferred into a 1.5-mL
snap/crimp champagne glass vial. The organic phase was
evaporated to dryness at 60 °C under vacuum (approximately
180 mbar) with a CentriVap concentrator from Labconco®
(Biolabo Scientific Instruments, Switzerland). The residue
was dissolved in 400 μL of reconstitution buffer (95 % ace-
tonitrile and 5 % of 5 mM ammonium acetate buffer at pH
5.72, with 0.1 % formic acid). An aliquot of 10 μL was
injected into the LC-MS/MS system. A blank sample (urine
from an abstinent person without internal standard) and a zero
sample (urine from an abstinent person with internal standard)
were included in each series. NAcTand taurine concentrations
were normalized to a creatinine value of 1 mg/mL in order to
correct for the urine’s dilution.
NAcT method validation
Method validation for the determination of NAcT, taurine, and
creatinine was performed according to FDA guidelines [10].
The presented procedure is based on a validation proce-
dure previously used for fatty acid ethyl ester determina-
tion [8]. Selectivity, linearity, limit of quantification, im-
precision (expressed as the relative standard deviation
Table 1 Mass spectrometric
parameters and retention time for
N-acetyltaurine, taurine, and
creatinine quantitation in urine
Compound Q1 (m/z) Q3 (m/z) Time (ms) DP (V) CE (V) CXP (V) RT (min)
NAcT SRM1 166 107 20 –120 –30 –16 4.2
NAcT SRM2 166 124 20 –120 –30 –16
NAcT-d4 170 128 20 –120 –30 –16
Creatinine SRM1 112 68 20 –55 –27 –8 5.0
Creatinine SRM2 112 41 20 –55 –27 –8
Creatinine-d3 115 42 20 –55 –27 –8
Taurine SRM1 123.9 79.8 20 –5 –26 –21 4.9
Taurine SRM2 123.9 123.9 20 –5 –10 –16
Taurine-d4 127.9 79.4 20 –105 –30 –19
Fig. 1 High field part of the
500 MHz 1H-NMR spectrum of
N-acetyltaurine dissolved in
DMSO-d6 recorded at 298 K. The
resonances at δ 1.79, 2.69, and
3.30 ppm belong to N-
acetyltaurine, while the resonance
at δ 2.88 ppm belongs to impurity
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(RSD%)), and accuracy (expressed as the mean relative
error (RE%)) were determined. According to the guide-
lines, the mean value for accuracy and imprecision of
quality control samples over six measurements, during
three series, had to be within ±15 % of the actual value,
except at the limit of quantification (LOQ), where a devi-
ation of up to ±20 % is accepted. Selectivity was deter-
mined by testing six blank urine samples from alcohol-
abstinent people (abstinence period of more than 2 weeks)
for interferences of endogenous matrix components or
metabolites, which could disturb the signals of the
analytes or internal standards. Additionally, the feasibility
of a standard addition-based method was investigated, by
using urine from an abstinent subject for the calibration.
For the final validation, working solutions containing
NAcT, taurine, and creatinine for the calibration samples
were prepared in water. Internal standard signal was used
in order to correct for losses during sample preparation
and ionization differences throughout the measurements.
The area of the analyte signal was thereby divided by the
area of the internal standard signal. The following con-
centrations of NAcT and taurine were used to establish
the calibration curve: 0.05, 0.1, 0.4, 2, 6, 12, and
50 μg/mL. For creatinine, the following concentrations
were used: 20, 100, 300, 600, and 2500 μg/mL. All
calibration curves were recorded twice on three different
days. Precision and accuracy were determined by
Fig. 2 Typical SRM1 chromatograms of a urine sample (a), with NAcT
concentrations in the endogenous range, and a calibrator sample (b) with
N-acetyltaurine 2.5 μg/mL, taurine 2.5 μg/mL, and creatinine 20 μg/mL
Fig. 3 Detailed chromatograms for N-acetyltaurine 2.5 μg/mL (a),
taurine 2.5 μg/mL (b), and creatinine 20 μg/mL (c) with SRM1,
SRM2, and internal standard (IS)
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preparing quality control (QC) samples spiked at differ-
ent NAcT and taurine concentration levels of 0.05, 0.5,
2.5, 5, and 32.5 μg/mL and creatinine levels of 20, 100,
200, and 1300 μg/mL. Carry-over was measured by
injecting the highest calibrator three times, followed by
a pure water sample to test if substances from the pre-
vious injection were carried over to the next measure-
ment. Matrix effects, recovery, and extraction efficiency
were analyzed by post-extraction addition in five differ-
ent urine samples [11].
Results and discussion
1H-NMR analysis of N-acetyltaurine
The high field part of the 1H-NMR spectrum of NAcT dis-
solved in DMSO-d6 is shown in Fig. 1. The purity of NAcT
was determined to be 94–95 % (see the BMaterial and
methods^ section).
NAcT method validation
The calibration curve for determining the selectivity had to be
measured in water, since the urine samples available contained
at least one of the analytes investigated. Alternatively, the use
of urine for establishing the calibration curve with incorpora-
tion of a correction for endogenous concentrations, based on a
linear regression, would be possible. However, as this method
does not allow quantifying below the concentration levels of
the urine itself, it was disregarded. Extracted ion chromato-
grams for a blank urine specimen and a calibrator are shown in
Fig. 2. The endogenous NAcT levels of 14 abstinent individ-
uals proved to be close to each other (0.5–2.3 μg/mL). To
analyze the linearity of the developed method, a linear cali-
bration model with weighting 1/x for NAcT and 1/x2 for tau-
rine and creatinine was used with spiked concentrations in the
calibration range. Extracted ion chromatograms for SRM1,
SRM2, and internal standards are shown in Fig. 3. For all
calibration curves, the correlation coefficients (R2) from least
squares regression were >0.9971, showing that the method is
linear. The following LOQs were established: 0.05 μg/mL for
Fig. 4 (a) Comparison of N-
acetyltaurine concentration with
and without correction for the
dilution of the urine. (b)
Comparison of EtG, EtS, BAC,
and NAcT in the same urine
sample
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NAcT and taurine and 20 μg/mL for creatinine. The limit of
detection (LOD) for NAcT and taurine was established by
gradually diluting the solutions until the chromatogram dis-
plays a signal-to-noise ratio of 3:1. This was achieved at a
concentration of 0.025 μg/mL. The LOD of creatinine was
below 1 μg/mL. Imprecision and accuracy were in acceptable
ranges: All QC samples had measured concentrations within
±15 % of target, in accordance with FDA guidelines [10]. The
mean intra-assay accuracy was 93–108 %, and the mean inter-
assay accuracy was 93–105 % of the target (see SS1). The
intra-assay imprecision was 0.7–14 %, and the inter-assay
imprecision was 0.6–4 % (see Electronic Supplementary
Material (ESM), Table S1). The relative ion intensity for
SRM2 was 31 ± 2 % for NAcT, 128 ± 20 % for taurine, and
439 ± 26 % for creatinine, compared to the ion intensity of
SRM1.
The carry-over for NAcTand taurine was below 0.1 %, and
the carry-over for creatinine was at 0.2 %. NAcT showed an
adequate extraction efficiency of 43 ± 9 %, the recovery was
35 ± 5%, and the matrix effects were 83 ± 7 %. For taurine, an
adequate extraction efficiency of 70 ± 22 % was obtained, the
recovery was 43 ± 16 %, and the matrix effects were 62
Fig. 5 Time course for N-
acetyltaurine for all eight subjects.
An overview of N-acetyltaurine
over 9 days can be seen in (a).
The first 24 h is depicted in (b)
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± 13 %. Finally, creatinine demonstrated an adequate extrac-
tion efficiency of 55 ± 13 %, the recovery was 53 ± 11 %, and
the matrix effects were 96 ± 12 %. Extracted quality control
samples in the range of sample concentrations (0.5, 5, and
32.5 μg/mL) were stable up to 72 h in the autosampler, after
three freeze thaw cycles at about −18 °C, and after storage for
7 days at 4 °C.
Drinking study
The group of participating volunteers was very homogenous
with respect to age and body mass index (BMI) with a mean
age of 23.5 ± 2.4 years (range 19–26 years) and a BMI of 21.3
± 2.5 kg/m2 (range 17.7–25.1 kg/m2). All blood samples col-
lected prior to the drinking test were negative for ethanol.
Endogenous NAcT levels in urine were present at a concen-
tration range of 1.0 to 2.3 μg/mL. Maximum BACs were
reached 1.75 h after the start of drinking with a mean maxi-
mum BAC of 0.76 ± 0.06 g/kg (range 0.66–0.84 g/kg). After
drinking the calculated amounts of vodka, mean maximum
NAcT concentrations of 14 ± 2.6 μg/mL (range 9–17.5 μg/
mL) were reached within 3 to 6 h. Figure 4 shows the time
courses of subject 1 for corrected and uncorrected NAcT con-
centrations. Overall, the correction for urine dilution by nor-
malization to creatinine (1 mg/mL) proved to be reasonable.
Detailed time courses for NAcT and BAC concentrations in
each subject can be found in SS2. All subjects showed similar
NAcT profiles, as clearly demonstrated in Fig. 5. The peak
concentrations and the elimination curve of NAcT in urine
were slightly shifted in time—compared to the blood alcohol
concentration. After 3.5 h, the concentration of NAcT in urine
started to decrease. Interestingly, the BAC reached zero after
about 7 h, while NAcT concentrations were still elevated in
urine. NAcT concentrations around the endogenous levels
were observed in the samples taken 24 h after the start of
drinking, while overnight (from 8 to 24 h after the start of
drinking), no samples were collected. A comparison of EtG,
EtS, and NAcT is shown in SS2 for all subjects. Considering
generation and elimination, the increase in EtG and EtS con-
centrations is clearly higher compared to NAcT, and the max-
imum peak concentration is shifted by about 2 to 4 h. After
24 h, EtG (1.95 ± 1.5 μg/mL) and EtS (0.65 ± 0.6 μg/mL)
were still detectable at low concentrations, while after 48 h,
EtG and EtS could not be detected anymore. In contrast to
NAcT, the two established markers EtG and EtS have the
advantage of being non-detectable when no alcohol was con-
sumed. This simplifies the interpretation of EtG and EtS re-
sults significantly, as endogenous and alcohol consumption-
related concentration changes are non-existing. The relation-
ship between taurine and NAcT concentrations could not be
found: NAcTconcentrations are about 33 ± 98% (range 0.34–
727 %) of the concentration of taurine.
Conclusion
The concentration of N-acetyltaurine, which can be detected
as an endogenous compound, significantly increases in urine
after ingestion of ethanol. Compared to BAC, NAcTexhibits a
longer detection window, but 24 h after a single ethanol uptake
leading to a BAC of 0.8 g/kg, NAcT concentrations have
decreased to endogenous concentrations. So far, we did not
find any indication that would indicate a prolonged elimina-
tion time for NAcT. The long-term consumption of ethanol
and the respective window of NAcT detectability after the last
consumption have not yet been investigated. The detection
window of EtG and EtS in urine proved to be longer than that
of NAcT, as low concentrations of these analytes were still
detectable after 24 h. Further studies are necessary to investi-
gate endogenous levels in abstinent people in order to estab-
lish a reference range in healthy subjects and to study NAcT
formation and elimination after regular consumption of higher
amounts of alcohol, in blood and urine. So far, the analysis of
NAcT levels bears no advantage when compared to EtG or
EtS analysis. However, it can serve as a further indication for
alcohol consumption. Additionally, the study of patients with
metabolic disorder, such as kidney insufficiency as a potential
cause for delayed NAcTclearance, or metabolic acidosis, e.g.,
in diabetes, as a reason for increased blood acetate concentra-
tion and thus increased endogenous NAcT levels, may be
investigated. Moreover, the effects of taurine metabolism dis-
order or taurine supplementation, e.g., in energy drinks, re-
main unknown.
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